Concert Pharmaceuticals Inc. buy klostergang
Start price
07.04.17
/
50%
€14.68
Target price
09.10.17
€22.55
Performance (%)
-5.90%
End price
09.10.17
€13.81
Summary
This prediction ended on 09.10.17 with a price of €13.81. With a performance of -5.90%, the BUY prediction by klostergang finished with a loss. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % | 45,80 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % | 78,69 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % | 45,87 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % | 58,52 % |
Comments by klostergang for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert has several big name partners and several "shots on goal" in its pipeline
Stifel Nicolaus and Aegis Capital reiterated Buy ratings on this small
cap "Tier 4" biotech stock yesterday (05.04.2017) with price targets of $31 and $25
(Laufzeit überschritten)